Ambu stock analysis
Ambu (AMBUN) Stock Price & Analysis
AMBUN Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- MXN 65.98B
- Enterprise Value
- MXN 18.17B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 37.7
- Beta
- N/A
- Next Earnings
- Jan 28, 2027 (Est.)
- EPS Estimate
- 2.05
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Ambu News
AMBUN FAQ
What is Ambu’s market cap?
When is Ambu’s upcoming earnings report date?
How were Ambu’s earnings last quarter?
Is Ambu overvalued?
Does Ambu pay dividends?
What is Ambu’s EPS estimate?
How many shares outstanding does Ambu have?
What happened to Ambu’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ambu?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Ambu
Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S is a global medical technology company specializing in the design, manufacture, and sale of advanced medical devices. The company serves hospitals, clinics, and emergency services worldwide, providing essential healthcare solutions across key disciplines such as visualization, anesthesia, and patient monitoring and diagnostics. Their extensive product portfolio includes sophisticated endoscopy equipment like bronchoscopes and dedicated monitors. For neurology, Ambu offers EEG and EMG electrodes, as well as tools for EMG-guided injections and intraoperative monitoring systems. Cardiology solutions feature ECG electrodes. A substantial portion of their offerings is dedicated to airway management and anesthesia, comprising specialized bronchoscopes, video laryngoscopes, various intubation tubes (double and single lumen), endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitation devices. Additionally, Ambu provides critical emergency and training products, including extrication collars, CPR breathing barriers, and training manikins.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Britt Meelby Jensen
- Employees
- 4,664
- Website
- www.ambu.com
- Address
- Baltorpbakken 13, Ballerup, CR, 2750, DK
Ambu (AMBUN) Earnings & Revenues
AMBUN Company Deck
AMBUN Earnings Call
Earnings Call SentimentPositive
The call was strongly optimistic, supported by 10.1% full-year organic growth, 13.9% Q4 growth, accelerating Endoscopy Solutions performance, a broad innovation pipeline, strong market share, and maintained long-term targets. The main challenges were limited A&PM and anesthesia growth, flat gross margin, tariff and TIMS-related costs, competitive pricing pressure in Urology, gradual product-launch ramps, and temporarily lower cash conversion. Overall, the highlights significantly outweighed the lowlights.
View all MX:AMBUN earnings summaries









